Belén Garijo: Our annual Merck Awards are here again
“Our annual Merck Awards are here again to bring our attention to the extraordinary talent, dedication, and innovation we have across Merck Group.
Each year, we honor those who pushed the boundaries of excellence on initiatives that truly matter to our future. Last night, we recognized outstanding teams for their contributions across key areas: innovation, fostering a culture of safety, and championing employee well-being.
A special congratulations to the winners of the CEO Award—our Animal Welfare teams—whose efforts to immediately improve animal welfare and reduce the need for animal testing have such a profound impact. Congratulations to all the winners! Your dedication, passion, and commitment inspire us all.”
Source: Belén Garijo/LinkedIn
More posts by Belén Garijo on oncodaily.com
Belén Garijo is the Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany. She joined the company in 2011 as Chief Operating Officer of the Biopharma business, becoming President and CEO of Healthcare in 2015.
In July 2020, Belén Garijo was appointed Vice Chairman of the Executive Board and Deputy CEO in addition to her role as CEO of the Healthcare business. She moved from Deputy CEO to CEO in May 2021.
Before joining Merck, Belén Garijo served as the Senior Vice President of Global Operations Europe at Sanofi-Aventis and Global Integration Leader of Genzyme after its acquisition by Sanofi.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023